Semawin 1mg Pen Injection is used to:

• Manage obesity in eligible adults as part of a weight-management plan.

• Manage overweight with a weight-related health condition.

• Support weight loss and long-term weight maintenance.

• Reduce hunger and food intake by increasing feelings of fullness.

The 1 mg dose is used after gradual dose escalation and should be taken only according to the schedule prescribed by your doctor.

Semaglutide activates GLP-1 receptors and helps regulate appetite and food intake. It also supports glucose regulation by increasing insulin release when blood glucose is high and reducing glucagon release.

Semaglutide delays gastric emptying and increases feelings of fullness. Together, these effects can reduce hunger and calorie intake and support weight management.

• Insulin or sulfonylureas: Can increase the risk of low blood sugar.

• Other Semaglutide-containing medicines: Should not be combined unless prescribed.

• Other GLP-1 receptor agonists: Do not combine without medical advice.

• Oral medicines: Delayed gastric emptying may affect the absorption of some oral medicines.

• Store in a refrigerator at 2°C to 8°C.

• Do not freeze.

• Do not use if frozen.

• Protect from light.

• Keep out of reach of children.

• Follow the pack instructions for storage after first use.

Semawin 1mg is injected under the skin once a week.

• Inject into the abdomen, thigh or upper arm.

• Rotate injection sites.

• It can generally be administered with or without food.

• Do not inject into a vein or muscle.

• Use a new needle for every injection.

• Never share the pen or needles.

• Use the 1 mg dose only when it forms part of your prescribed dose-escalation schedule.

The Semawin 1 mg pen contains 4 mg/3 mL of Semaglutide.

Common side effects include:

• Nausea

• Vomiting

• Diarrhoea

• Constipation

• Abdominal pain

• Bloating

• Indigestion

• Headache

• Dizziness

• Decreased appetite

Serious Side Effects

Seek medical attention for severe persistent abdominal pain, severe allergic reactions, persistent vomiting or diarrhoea, gallbladder symptoms, significant changes in vision, or low blood sugar symptoms.

• Follow your prescribed weekly schedule.

• Do not increase the dose yourself.

• Eat smaller meals if you develop nausea.

• Drink sufficient fluids.

• Rotate injection sites.

• Use a new needle for each injection.

• Tell your doctor before surgery or deep sedation.

• Report severe abdominal pain or significant vision changes promptly.